PECAM1 and breast cancer: Interestingly, blood vessels in adjacent tissue also showed PEAK1 immunoreactivity, but it was restricted to the abluminal regions of vessels, while in breast cancer samples, it was highly expressed on the luminal side of vessels, where it strongly co-localized with CD31-positive ECs (Fig. 9b).